Registry Study of Pharmacotherapy and Clinical Outcomes in Elderly Patients With Coronary Heart Disease (PHARM-ageing)

Not yet recruiting

• Conditions: Coronary Heart Disease; Elderly Patients; Drug Therapy; Clinical Outcomes

• Registration Number: NCT05246722
• Lead Sponsor: Beijing Anzhen Hospital

Brief Summary

A registry study on drug therapy and clinical outcomes in elderly patients with coronary heart disease

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-01-13
• Status Verified: 2022-02
• Study Start: 2022-02
• Study First Submitted QC: 2022-02-09
• Last Update Submitted: 2022-02-09
• Study First Posted: 2022-02-18
• Last Update Posted: 2022-02-18
• Primary Completion: 2024-12
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 15000

Inclusion Criteria

• Informed consent has been signed
• Patients diagnosed in our hospital with coronary heart disease
• Age ≥65 years

Exclusion Criteria

• Severe lack of important information such as history of previous medication, history of previous disease, history of surgery.
• Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
main adverse cardiovascular and cerebrovascular events (MACCE)	up to 3 years	MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization

Secondary Outcome Measures

Name	Time	Method
Adverse drug reaction	up to 3 years	Adverse drug reaction will be defined as any adverse reactions in the patients